J. Sleasman

N. Day, J. Sleasman, P. Emmanuel, 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cells

S. Pittaluga, V. Kanderova, L. Notarangelo, 2022, Nature Immunology.

Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort

A. Rosenberg, J. Sleasman, P. Kishnani, 2020, Frontiers in Immunology.

Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis.

L. Notarangelo, G. Giardino, C. Pignata, 2019, American journal of human genetics.

Con A-induced suppressor cell function depends on the activation of the CD4+CD45RA inducer T cell subpopulation.

J. Sleasman, D. Barrett, M. Henderson, 1991, Cellular immunology.

Molecular analysis of highly enriched populations of T-cell-depleted monocytes

J. Sleasman, M. Goodenow, L. Aleixo, 1995, Clinical and diagnostic laboratory immunology.

Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report.

J. Aranda, S. Skoda-Smith, J. Sleasman, 2002, Transplantation.

Hypereosinophilic syndrome and hemimelia in a patient with chromosome 6p22.3 deletion

Melissa L. Crenshaw, J. Sleasman, Robyn Schickler, 2014, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Novel pathogenic variants in FOXP3 in fetuses with echogenic bowel and skin desquamation identified by ultrasound

Q. K. Tan, R. Stevenson, S. B. Wechsler, 2017, American journal of medical genetics. Part A.

Profound reduction of invariant natural killer T cells in the peripheral blood of a patient with interleukin-1 receptor-associated kinase 4 deficiency.

N. Day, S. Haraguchi, J. Sleasman, 2010, Immunology letters.

Soluble CD14, CD163, and CD27 biomarkers distinguish ART‐suppressed youth living with HIV from healthy controls

S. Wallet, S. Nichols, J. Sleasman, 2018, Journal of leukocyte biology.

Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children.

J. Sleasman, Wasu Kamchaisatian, N. Tangsinmankong, 2006, The Journal of allergy and clinical immunology.

Antiphospholipid antibodies in pediatric lupus nephritis.

S. Massengill, E. Ayoub, J. Sleasman, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Complete DiGeorge syndrome associated with CHD7 mutation.

M. Dorsey, J. Sleasman, M. Loscalzo, 2007, The Journal of allergy and clinical immunology.

Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis

R. Fennell, J. Sleasman, A. Iravani, 1986, European Journal of Pediatrics.

Sexually transmitted infections and immune activation among HIV-infected but virally suppressed youth on antiretroviral therapy.

J. Sleasman, M. Goodenow, J. Bethel, 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Combined immunodeficiency due to the selective absence of CD4 inducer T lymphocytes.

T. Tedder, J. Sleasman, D. Barrett, 1990, Clinical immunology and immunopathology.

Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis

Sophie Steeland, A. Azar, K. Winthrop, 2022, Autoimmunity.

Multilocular thymic cysts in children with human immunodeficiency virus infection: clinical and pathologic aspects.

E. Jaffe, H. U. Kontny, J. Sleasman, 1997, The Journal of pediatrics.

Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy

M. Wallet, J. Sleasman, M. Goodenow, 2010, AIDS.

Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia.

A. S. Klein, J. Sleasman, C. Hemenway, 1993, American journal of diseases of children.

Efficacy and safety of privigen in children and adolescents with primary immunodeficiency.

R. Nelson, J. Church, J. Sleasman, 2009 .

IFNgamma primes macrophages for inflammatory activation by high molecular weight hyaluronan.

S. Wallet, M. Wallet, J. Sleasman, 2010, Cellular immunology.

Brief Report: Macrophage Activation in HIV-Infected Adolescent Males Contributes to Differential Bone Loss by Sex: Adolescent Trials Network Study 021.

G. Aldrovandi, K. Mulligan, Fan Li, 2016, Journal of acquired immune deficiency syndromes.

Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B.

D. Harris, G. Aldrovandi, R. Fielding, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long‐term outcomes of 176 patients with X‐linked hyper‐IgM syndrome treated with or without hematopoietic cell transplantation

L. Notarangelo, J. Chou, C. Cunningham-Rundles, 2017, The Journal of allergy and clinical immunology.

Effects of in vitro Brevetoxin Exposure on Apoptosis and Cellular Metabolism in a Leukemic T Cell Line (Jurkat)

R. Pierce, J. Sleasman, C. Walsh, 2008, Marine drugs.

Tenofovir has minimal effect on biomarkers of bone health in Youth with HIV receiving initial antiretroviral therapy.

G. Aldrovandi, Cliburn Chan, G. Venturi, 2019, AIDS research and human retroviruses.

A model for alignment of Env V1 and V2 hypervariable domains from human and simian immunodeficiency viruses.

S. Lamers, J. Sleasman, M. Goodenow, 1996, AIDS research and human retroviruses.

Plasma Thrombospondin as an Indicator of Intravascular Platelet Activation in Patients with Vasculitis

P. Klein, J. Sleasman, K. Kao, 1987, Thrombosis and Haemostasis.

Total serum immunoglobulin A in ALS

M. ElMallah, R. Bedlack, J. Sleasman, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.

R. Nelson, J. Church, J. Sleasman, 2001, Pediatrics.

Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials Group.

J. Lindsey, L. Mofenson, S. Spector, 1999, The Pediatric infectious disease journal.

FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning

M. Dorsey, J. Sleasman, A. Petrovič, 2009, Immunologic research.

Δ9-Tetrahydrocannabinol Treatment During Human Monocyte Differentiation Reduces Macrophage Susceptibility to HIV-1 Infection

T. Klein, J. Sleasman, M. Goodenow, 2014, Journal of Neuroimmune Pharmacology.

Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects

T. Manini, M. Pahor, M. Wallet, 2015, BMC Immunology.

Molecular Docking-Based Screening for Novel Inhibitors of the Human Immunodeficiency Virus Type 1 Protease that Effectively Reduce the Viral Replication in Human Cells

B. Dunn, D. Ostrov, C. Mavian, 2020, bioRxiv.

HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inﬂammation and Viral Replication

M. Wallet, J. Sleasman, M. Goodenow, 2017 .

HIV-1 Activates Macrophages Independent of Toll-Like Receptors

J. Sleasman, C. Coberley, M. Goodenow, 2008, PloS one.

Acrodermatitis enteropathica-like eruption and food allergy.

J. Sleasman, N. Tangsinmankong, Noorbibi K. Day-Good, 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Natural history of neonatal herpes simplex virus infections in the acyclovir era.

S. Soong, D. Powell, W. Gruber, 2001, Pediatrics.

Acute retinal necrosis after chickenpox in a patient with acquired immunodeficiency syndrome.

S. Whitcup, J. Sleasman, S. Friedman, 1993, Archives of ophthalmology.

Increased replication of non-syncytium-inducing HIV type 1 isolates in monocyte-derived macrophages is linked to advanced disease in infected children.

W. Andiman, L. Alexander, K. Peden, 2002, AIDS research and human retroviruses.

A Phase I/II Study of the Protease Inhibitor Ritonavir in Children With Human Immunodeficiency Virus Infection

S. Steinberg, R. Nelson, A. Hsu, 1998, Pediatrics.

Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission.

S. Lamers, J. Sleasman, M. Goodenow, 1994, The Journal of clinical investigation.

Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.

J. Sleasman, P. Emmanuel, Wasu Kamchaisatian, 2004, The Journal of allergy and clinical immunology.

Two-Year Clinical and Immune Outcomes in Human Immunodeficiency Virus–Infected Children Who Reconstitute CD4 T Cells Without Control of Viral Replication After Combination Antiretroviral Therapy

J. Sleasman, M. Goodenow, Guity Ghaffari, 2004, Pediatrics.

Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.

B. Dunn, J. Sleasman, E. Perez, 2002, Virology.

Association Between Breast Milk Bacterial Communities and Establishment and Development of the Infant Gut Microbiome

Kyle Bittinger, Frederic D. Bushman, F. Bushman, 2017, JAMA pediatrics.

HIV‐1 fitness and macrophages

J. Sleasman, M. Goodenow, D. L. Tuttle, 2003, Journal of leukocyte biology.

Genetically and epidemiologically related “non‐syncytium‐inducing” isolates of HIV‐1 display heterogeneous growth patterns in macrophages

W. Andiman, G. Miller, J. Sleasman, 2000, Journal of medical virology.

Human Lymphocyte Proliferation Responses following Primary Immunization with Rabies Vaccine as Neoantigen

J. Sleasman, M. Goodenow, B. Bender, 2001, Clinical Diagnostic Laboratory Immunology.

Rapid telomere shortening in children.

D. Dimitrov, D. Gee, R. Biggar, 1999, Blood.

Tolerability of a New 10% Liquid Immunoglobulin for Intravenous Use, Privigen®, at Different Infusion Rates

J. Sleasman, M. Stein, M. Rojavin, 2010, Journal of Clinical Immunology.

Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.

J. Church, H. Peter, R. Wasserman, 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Impact on Genetic Networks in Human Macrophages by a CCR5 Strain of Human Immunodeficiency Virus Type 1

H. Baker, M. Popp, J. Sleasman, 2004, Journal of Virology.

Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo

S. Lamers, J. Sleasman, M. Goodenow, 1993, Journal of virology.

Expression of CCR5 Increases during Monocyte Differentiation and Directly Mediates Macrophage Susceptibility to Infection by Human Immunodeficiency Virus Type 1

J. Harrison, J. Sleasman, M. Goodenow, 1998, Journal of Virology.

Cytochalasins enhance the proliferation of CD4 cells through the CD3-Ti antigen receptor complex or the CD2 molecule through an effect on early events of activation.

J. Daley, A. Yamada, J. Sleasman, 1991, Journal of immunology.

Normal IgH Repertoire Diversity in an Infant with ADA Deficiency After Gene Therapy

Jiqiang Yao, D. Kohn, J. Sleasman, 2021, Journal of Clinical Immunology.

Neonatal Hematology: Immunodeficiency diseases of the neonate

J. Sleasman, J. Wynn, M. Saxonhouse, 2013 .

ICON: The Early Diagnosis of Congenital Immunodeficiencies

J. B. Oliveira, F. Deist, C. Picard, 2014, Journal of Clinical Immunology.

Thymic output markers indicate immune dysfunction in DiGeorge syndrome.

N. Day, S. Haraguchi, J. Sleasman, 2006, The Journal of allergy and clinical immunology.

Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor

B. Dunn, R. Lawrence, J. Sleasman, 2009, AIDS.

Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children

J. Sleasman, M. Goodenow, C. Rodriguez, 2008, Immunologic research.

13. HIV-1 infection.

J. Sleasman, M. Goodenow, 2003, The Journal of allergy and clinical immunology.

Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages.

R. Nelson, A. Hutson, M. Baseler, 1999, The Journal of pediatrics.

High-resolution deep sequencing reveals biodiversity, population structure, and persistence of HIV-1 quasispecies within host ecosystems

Wei Hou, Li Yin, Brent P Gardner, 2012, Retrovirology.

Phylodynamics of HIV-1 in Lymphoid and Non-Lymphoid Tissues Reveals a Central Role for the Thymus in Emergence of CXCR4-Using Quasispecies

Marco Salemi, Rebecca R. Gray, B. Burkhardt, 2007, PloS one.

The Association Between Immunodeficiency and the Development of Autoimmune Disease

J. Sleasman, 1996, Advances in dental research.

Juvenile rheumatoid arthritis in velo-cardio-facial syndrome: coincidence or unusual complication?

C. Williams, S. Rasmussen, E. Ayoub, 1996, American journal of medical genetics.

Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome (AIDS)

J. Sleasman, M. Goodenow, 1998 .

Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency

L. Notarangelo, J. Walter, L. Henderson, 2020, Frontiers in Immunology.

Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency.

L. Notarangelo, J. Walter, R. Geha, 2019, The journal of allergy and clinical immunology. In practice.

T lymphocyte depletion of human peripheral blood and bone marrow using monoclonal antibodies and magnetic microspheres.

A. Gee, J. Sleasman, D. Barrett, 1987, Bone marrow transplantation.

Diagnosis of Immunodeficiency Diseases

J. Sleasman, G. Virella, 2001 .

Differential controls of MAIT cell effector polarization by mTORC1/mTORC2 via integrating cytokine and costimulatory signals

X. Zhong, J. Sleasman, Jinhai Xie, 2021, Nature Communications.

A Novel Mutation CHS1 (LYST) Mutation: Osteomyelitis in a Child with Chediak-Higashi Syndrome

M. Dorsey, J. Sleasman, A. Petrovič, 2010 .

Independent Variation andPositive Selection inenv Vland V2Domainswithin Maternal-Infant Strains ofHuman Immunodeficiency VirusType1 InVivo

S. Lamers, J. Sleasman, K. A. Barrie, 1993 .

Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children.

S. Wu, J. Sleasman, M. Goodenow, 2003, The Journal of infectious diseases.

T-Cell Receptor Vβ Repertoire CDR3 Length Diversity Differs within CD45RA and CD45RO T-Cell Subsets in Healthy and Human Immunodeficiency Virus-Infected Children

J. Sleasman, M. Goodenow, W. T. McCormack, 2000, Clinical Diagnostic Laboratory Immunology.

T-Cell Receptor Vb Repertoire CDR3 Length Diversity Differs within CD45RA and CD45RO T-Cell Subsets in Healthy and Human Immunodeficiency Virus-Infected Children

J. Sleasman, M. Goodenow, W. T. McCormack, 2000 .

T-Cell Receptor V b Repertoire CDR 3 Length Diversity Differs within CD 45 RA and CD 45 RO T-Cell Subsets in Healthy and Human Immunodeficiency Virus-Infected Children

J. Sleasman, M. Goodenow, W. T. McCormack, 2000 .

Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells.

J. Sleasman, M. Goodenow, W. Hou, 2008, The Journal of allergy and clinical immunology.

Human immunodeficiency virus type 1 (HIV‐1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages

J. Sleasman, C. Coberley, M. Goodenow, 2003, Journal of leukocyte biology.

HIV-1 infection

J. Sleasman, M. Goodenow, John W. Sleasman, 2003 .

Higher soluble CD14 levels are associated with lower visuospatial memory performance in Youth with HIV (YWH).

S. Woods, S. Nichols, G. Venturi, 2019, AIDS.

Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.

D. Harris, S. Stoszek, G. Aldrovandi, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onset

M. Atkinson, K. Grebe, C. Wasserfall, 2003, Pediatric diabetes.

Immune Response: Antigens, Lymphocytes and Accessory Cells

D. Farber, J. Sleasman, 2007 .

Immunomagnetic selection of purified monocyte and lymphocyte populations from peripheral blood mononuclear cells following cryopreservation

J. Sleasman, M. Goodenow, M. Rojas, 1997, Clinical and diagnostic laboratory immunology.

Funding Pediatric Subspecialty Training: Are T32 Grants the Future?

D. Benjamin, W. Steinbach, J. Sleasman, 2018, Jornal de Pediatria.

Thymic Epithelial Cell-Derived IL-15 and IL-15 Receptor α Chain Foster Local Environment for Type 1 Innate Like T Cell Development

S. Luckhart, X. Zhong, J. Sleasman, 2021, Frontiers in Immunology.

Higher soluble CD14 levels are associated with lower visuospatial memory performance in youth with HIV.

S. Woods, S. Nichols, G. Venturi, 2019 .

Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061

K. Squires, J. Sleasman, B. Kapogiannis, 2015, Journal of acquired immune deficiency syndromes.

Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.

J. Sleasman, D. Wara, S. Pahwa, 2007, Journal of Allergy and Clinical Immunology.

Immune deficiencies , infection , and systemic immune disorders Genome-wide association identifies diverse causes of common variable immunodeficiency

Joseph T. Glessner, J. Glessner, H. Hakonarson, 2011 .

Human anti-pneumococcal polysaccharide antibodies are secreted by the CD5- B cell lineage.

D. Schatz, J. Sleasman, M. Steinitz, 1992, Cellular immunology.

Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP)

S. Marhefka, J. Sleasman, J. Rodrigue, 2004, AIDS care.

Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response.

Maureen M Goodenow, B. Dunn, J. Sleasman, 2008, Virology.

Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency

M. Dorsey, J. Sleasman, C. Duff, 2015, Clinical and experimental immunology.

Concordance between self-reported substance use and toxicology among HIV-infected and uninfected at risk youth.

S. Nichols, P. Garvie, J. Sleasman, 2014, Drug and alcohol dependence.

Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients.

B. Burkhardt, A. Hutson, B. Dunn, 2001, The Journal of infectious diseases.

Δ9-Tetrahydrocannabinol (THC) enhances lipopolysaccharide-stimulated tissue factor in human monocytes and monocyte-derived microvesicles

N. Mackman, T. Klein, J. Sleasman, 2015, Journal of Inflammation.

Trajectories of Depressive Symptoms, Neurocognitive Function, and Viral Suppression With Antiretroviral Therapy Among Youth With HIV Over 36 months

S. Woods, S. Nichols, P. Garvie, 2021, Journal of acquired immune deficiency syndromes.

Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV

S. Woods, S. Nichols, P. Garvie, 2015, Journal of NeuroVirology.

Flebogamma® 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases

H. Ochs, T. Craig, J. Sleasman, 2016, Journal of Clinical Immunology.

Flebogamma® 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases

H. Ochs, T. Craig, J. Sleasman, 2016, Journal of Clinical Immunology.

Bioavailability of IgG Administered by the Subcutaneous Route

J. Orange, J. Sleasman, S. Jolles, 2012, Journal of Clinical Immunology.

Immune globulin subcutaneous, human - klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study.

I. Hussain, W. Lumry, J. Sleasman, 2019, Immunotherapy.

Bioavailability of IgG Administered by the Subcutaneous Route

J. Orange, J. Sleasman, S. Jolles, 2012, Journal of Clinical Immunology.

Subcutaneous immunoglobulin replacement therapy with Hizentra®, the first 20% SCIG preparation: a Practical approach

J. Sleasman, S. Jolles, 2011, Advances in therapy.

Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.

E. Kabagambe, J. Sleasman, B. Kapogiannis, 2013, AIDS research and human retroviruses.

IgM Repertoire Biodiversity is Reduced in HIV-1 Infection and Systemic Lupus Erythematosus

Brent P Gardner, Yunpeng Cai, Li Liu, 2013, Front. Immunol..

HIV-1 Infection Primes Macrophages Through STAT Signaling to Promote Enhanced Inflammation and Viral Replication.

M. Wallet, J. Sleasman, M. Goodenow, 2017, AIDS research and human retroviruses.

Protease Inhibitors and HIV-1 Genetic Variability in Infected Children

J. Sleasman, E. Perez, M. Goodenow, 2002 .

Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.

S. Steinberg, R. Nelson, C. Mackall, 2001, The Journal of infectious diseases.

Evolutionarily Conserved Epitopes on Human Immunodeficiency Virus Type 1 (HIV-1) and Feline Immunodeficiency Virus Reverse Transcriptases Detected by HIV-1-Infected Subjects

J. Levy, J. Sleasman, M. Rathore, 2013, Journal of Virology.

Arrested rearrangement of TCR V beta genes in thymocytes from children with X-linked severe combined immunodeficiency disease.

J. Sleasman, M. Goodenow, J. George, 1994, Journal of immunology.

Bacillus species infection of the skin as a presentation of severe combined immunodeficiency disease.

J. Sleasman, M. Ford, L. S. Machado, 1998, Journal of the American Academy of Dermatology.

Lipopolysaccharide and soluble CD14 in cord blood plasma are associated with prematurity and chorioamnionitis

J. Sleasman, N. Funderburg, A. Luciano, 2014, Pediatric Research.

The Regulatory B Cell Compartment Expands Transiently During Childhood and Is Contracted in Children With Autoimmunity

T. Tedder, G. Venturi, J. Sleasman, 2017, Arthritis & rheumatology.

Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.

N. Day, S. Haraguchi, R. Good, 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Antiretroviral Therapy Restores Diversity in the T-Cell Receptor Vβ Repertoire of CD4 T-Cell Subpopulations among Human Immunodeficiency Virus Type 1-Infected Children and Adolescents

J. Sleasman, M. Goodenow, W. Hou, 2009, Clinical and Vaccine Immunology.

Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth.

J. Sleasman, B. Kapogiannis, Craig M. Wilson, 2012, AIDS patient care and STDs.

Novel CYBA Gene Mutation in a Patient with Chronic Granulomatous Disease Associated with Autoimmune Hepatitis

J. Sleasman, A. Petrovič, A. Bagg, 2007 .

The HIV‐1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation

Brent P Gardner, M. Wallet, J. Sleasman, 2012, Journal of leukocyte biology.

Biomarkers detected in cord blood predict vaccine responses in young infants

G. Aldrovandi, Cliburn Chan, G. Venturi, 2023, Frontiers in Immunology.

Developmental regulation of P‐glycoprotein activity within thymocytes results in increased anti‐HIV protease inhibitor activity

S. Haraguchi, J. Sleasman, M. Goodenow, 2011, Journal of leukocyte biology.

Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression.

J. Sleasman, B. Kapogiannis, Craig M. Wilson, 2009, AIDS research and human retroviruses.

CD4+ memory T cells are the predominant population of HIV‐1‐infected lymphocytes in neonates and children

S. Skoda-Smith, J. Sleasman, M. Goodenow, 1996, AIDS.

HIV and older adults: clinical outcomes in the era of HAART.

H. Yarandi, C. Uphold, J. Sleasman, 2004, Journal of gerontological nursing.

Regulation of Intrinsic and Bystander T Follicular Helper Cell Differentiation and Autoimmunity by Tsc1

Danli Xie, X. Zhong, J. Sleasman, 2021, Frontiers in Immunology.

Brief report: assessing adherence to pediatric antiretroviral regimens using the 24-hour recall interview.

S. Marhefka, J. Sleasman, C. Mellins, 2006, Journal of pediatric psychology.

Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.

W. Farmerie, B. Dunn, S. Lamers, 1996, Virology.

Neonatal Hematology: Immunodeficiency diseases of the neonate

J. Sleasman, J. Wynn, M. Saxonhouse, 2013 .

Worlds apart: the impact of antiretroviral therapy on the treatment and prevention of pediatric HIV infection.

J. Sleasman, 2000 .

High-resolution deep sequencing reveals biodiversity, population structure, and persistence of HIV-1 quasispecies within host ecosystems

Brent P Gardner, W. Farmerie, M. Salemi, 2012, Retrovirology.

Pathogenesis and natural history of HIV infection.

J. Sleasman, M. Goodenow, 1991, The Journal of the Florida Medical Association.

The Safety and Efficacy of High-Dose (HD) Acyclovir (ACV) in Neonatal Herpes Simplex Virus (HSV) Infections

S. Soong, D. Powell, W. Gruber, 1999 .

Monogenic Early-Onset Lymphoproliferation and Autoimmunity: The Natural History of STAT3 GOF Syndrome.

K. Schwarz, M. Weinrich, F. Rieux-Laucat, 2022, The Journal of allergy and clinical immunology.

Genome-wide association identifies diverse causes of common variable immunodeficiency.

J. Glessner, H. Hakonarson, Cecilia Kim, 2011, The Journal of allergy and clinical immunology.

B. Dunn, J. Sleasman, M. Goodenow, 2008, Virology.

Recalcitrant Rhinosinusitis, Innate Immunity, and Mannose-Binding Lectin

J. Sleasman, D. Lanza, J. Justice, 2015, The Annals of otology, rhinology, and laryngology.

Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency

M. Dorsey, J. Sleasman, D. Nguyen, 2015, Clinical and experimental immunology.

Psychrobacter immobilis Septicemia in a Boy with X-linked Chronic Granulomatous Disease and Fulminant Hepatic Failure

G. Aldrovandi, J. Sleasman, E. Perez, 2013, Journal of Clinical Immunology.

FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning

M. Dorsey, J. Sleasman, M. Morrow, 2009, Immunologic research.